MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling.
Huang S, Hölzel M, Knijnenburg T, Schlicker A, Roepman P, McDermott U, Garnett M, Grernrum W, Sun C, Prahallad A, Groenendijk FH, Mittempergher L, Nijkamp W, Neefjes J, Salazar R, Ten Dijke P, Uramoto H, Tanaka F, Beijersbergen RL, Wessels LF, Bernards R.
Huang S, et al.
Cell. 2012 Nov 21;151(5):937-50. doi: 10.1016/j.cell.2012.10.035.
Cell. 2012.
PMID: 23178117
Free PMC article.